Flamicort 40mg/ml injection
Ingredients in every ml
Each package contains
|ATC Level 1||H - Systemic hormonal preparations; excluding sex hormones and insulins|
|ATC Level 2||H02 - Corticosteroids for Systemic Use|
|ATC Level 3||H02A - Corticosteroids for Systemic Use; Plain|
12 YEARS OLD AND ABOVE
Initial dose: 60 mg injected deeply into the gluteal muscle.
Dosage is usually adjusted within the range of 40-80 mg, depending upon patient’s response and duration of relief. Some patients may be well controlled on dosages as low as 20 mg or less.
6 TO 12 YEARS OLD
Initial dose: 40 mg
Dosage depends more on the severity of symptoms than on age or weight.
0 TO 6 YEARS OLD
Insufficient clinical experience with FLAMICORT intramuscular injection to recommend its use in children under six years of age.
Where oral therapy is not feasible or is temporarily undesirable in the judgement of the physician, Flamicort injection 40 mg/ml is indicated for intramuscular use as follows:
1. Allergic diseases.
2. Rheumatic disorders
As adjunctive therapy for short-term administration (to tide the patient over an acute episode exacerbation) in: post-traumatic osteoarthritis, synovitis of osteoarthritis, rheumatoid arthritis, acute or sub-acute bursitis, epicondylitis, acute nonspecific tenosynovitis, acute gouty arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile rheumatoid arthritis.
3. Collagen diseases
During an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus, acute rheumatic carditis.
4. Dermatologic diseases
Pemphigus, severe erythema multiforme (Stevens-Johnson syndrome), exfoliative dermatitis, bullous dermatitis herpetiformis, severe seborrheic dermatitis, severe psoriasis.
5. Edematous state
To induce diuresis or remission of proteinuria in the nephrotic syndrome, without uremia, of the idiopathic type or that due to lupus erythematosus.